| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,875,903 | 1,465,180 | 1,148,207 | 1,415,418 | | Cost of Revenue | 735,880 | 582,505 | 488,939 | 624,572 | | | Gross Profit | 1,140,023 | 882,675 | 659,268 | 790,846 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 546,961 | 546,126 | 491,311 | 540,460 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 37,097 | 40,222 | 43,616 | 49,475 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 555,965 | 296,327 | 124,341 | 200,911 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (13,849) |
-
|
-
| | Earnings Before Interest And Taxes | 555,965 | 282,478 | 124,341 | 200,911 | | Interest Expense | 17,827 | 18,499 | 20,591 | 15,438 | | Income Before Tax | 538,138 | 263,979 | 103,750 | 185,473 | | Income Tax Expense | 195,882 | 96,088 | 37,765 | 69,552 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 342,256 | 167,891 | 65,985 | 115,921 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 342,256 | 167,891 | 65,985 | 115,921 | | Preferred Stock And Other Adjustments | (6,145) | (3,798) | (2,981) |
-
| | | Net Income Applicable To Common Shares | $336,111 | $164,093 | $63,004 | $115,921 |
|
0.11% Nasdaq 
0.01%
Income Statement
